Kala Bio (KALA) Return on Assets (2017 - 2026)
Kala Bio (KALA) posted Return on Assets of 0.03% for Q1 2026, down 21.96% sequentially from 0.02% in Q4 2025, and down 2.0% YoY from 0.03% in Q1 2025.
Kala Bio (KALA) Return on Assets (2017 - 2026) Analysis & Trends
Kala Bio has reported Return on Assets for 10 years, with the latest figure at 0.03% in Q1 2026.
- Quarterly Return on Assets fell 2.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 2.0% YoY) and the FY2025 annual result came in at 0.06%, down 2.0% from the prior year.
- Return on Assets retreated to 0.03% in Q1 2026 per KALA's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q3 2023 and troughed at 0.03% in Q1 2026.
- A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2023 and 2025: Return on Assets rose 1 bps in 2023, then declined 2 bps in 2025.
- Over 5 years, Return on Assets stood at 0.01% in 2022, then gained by 28 bps to 0.01% in 2023, then dropped by 12 bps to 0.01% in 2024, then plunged by 196 bps to 0.02% in 2025, then slipped by 22 bps to 0.03% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.03%, 0.02%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |